Deliverables & Publications

Deliverables & Publications

Published Articles

Stafford GP, Parker JL, Amabebe E, Kistler J, Reynolds S, Stern V, Paley M, Anumba DOC. Spontaneous preterm birth is associated with differential expression of vaginal metabolites by Lactobacilli-dominated microflora. Front. Physiol. 2017, 8:615. doi: 10.3389/fphys.2017.00615, PMID:28878691, PMCID: PMC5572350

Narice BF, Green NH, MacNeil S, Anumba D. Second Harmonic Generation microscopy reveals collagen fibres are more organised in the cervix of postmenopausal women. Reprod Biol Endocrinol. 2016 Oct 21; 14(1):70. doi: 10.1186/s12958-016-0204-7. PMID: 27769268; PMCID: PMC5073459

Amabebe E, Reynolds S, Stern V, Stafford G, Paley M, Anumba DO. Cervicovaginal fluid acetate: a metabolite marker of preterm birth in symptomatic pregnant women. Front Med (Lausanne). 2016 Oct 10; 3:48. doi:10.3389/fmed.2016.00048. PMID: 27777928; PMCID: PMC5056530

Amabebe E, Reynolds SR, Stern VL, Parker JL, Stafford GP, Paley M, Anumba DOC. Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy. Metabolomics. 2016 Mar 8; 12(67):1-11. doi:10.1007/s11306-016-0985-x. Epub 2016 Mar 8. PMID: 27065760; PMCID: PMC4783437

Errors in prenatal diagnosis

Management of women with a previous preterm birth

External Sources

Born Too Soon: The Global Action Report on Preterm Birth

Conference Proceedings

Amabebe E, Stern V, Chapman D, Anumba. Predictive markers of inflammation-associated preterm birth in asymptomatic pregnant women: Correlation of mid-gestational changes in cervicovaginal RANTES and IL-1β with fetal fibronectin. BJOG. 2017; 124(S2):126-7 (P.PO. 15). doi:10.1111/1471-0528.14589.

Amabebe E, Reynolds S, Stern V, Stafford G, Paley M, Anumba D. Decreased cervicovaginal fluid glutamate improves the predictive value of acetate for risk of preterm delivery within two weeks of presentation with threatened preterm labour. BJOG. 2017; 124(S2):127 (P.PO. 17). doi:10.1111/1471-0528.14589.

Chapman D, Amabebe E, Stern V, Anumba D. Mid-trimester changes in cervicovaginal fluid cytokine profile of asymptomatic women at risk of preterm birth correlate with gestational changes in prevalence of bacterial vaginosis - associated organisms. BJOG. 2017; 124 (S2):131 (P.PO. 28). doi:10.1111/1471-0528.14589.

Amabebe E, Stern V, Chapman D, Anumba. The mid-gestational changes in cervicovaginal RANTES and IL-1β correlate with fetal fibronectin in asymptomatic pregnant women and are predictive markers of inflammation-associated preterm birth. Reprod Sci. 2017; 24(Suppl 1):108A-109A (T-013).

Amabebe E, Reynolds S, Stern V, Stafford G, Paley M, Anumba D. Prognostic capacity of cervicovaginal fluid acetate-glutamate ratio for risk of preterm delivery within two weeks of presentation with symptoms of preterm labour. Reprod Sci. 2017; 24(Suppl 1):175A (F-018).

Chapman D, Amabebe E, Stern V, Anumba D. Mid-trimester changes in cervicovaginal fluid cytokine profile of asymptomatic women as early indicators of preterm birth. Reprod Sci. 2017; 24(Suppl 1):237A (S-006).

Amabebe E, Reynolds S, Stern V, Parker J, Stafford G, Paley M, Anumba D. Cervicovaginal fluid acetate, a marker for preterm birth in symptomatic pregnant women. BJOG. 2016; 123(Suppl 1):44 (PP. 12). doi:10.1111/1471-0528.13989.

Parker J, Stafford G, Stern V, Amabebe E, Reynolds S, Paley M, Anumba D. Cervicovaginal microbiome and metabolite profiles are altered remote from term un women who subsequently deliver preterm. BJOG 2016, 123 (Suppl 1):45(PP. 16). doi:10.1111/1471-0528.13989.

Stern V, Amabebe E, Anumba D. The association between cervicovaginal fetal fibronectin, the metabolic markers of the vaginal microbiome, and preterm birth. BJOG. 2016; 123(Suppl 1):79-80 (PF. 48). doi.10.1111/1471-0528.13986.

Narice B, Green N, MacNeil S, Anumba D. The Use of Second-Harmonic-Generation (SHG) to Assess the Impact of Menopause on the Orientation of Collagen Fibres in the Human Cervix. Reprod Sci. 2016; 23(Suppl 1):214A (F-090).

Amabebe E, Reynolds S, Stern V, Parker J, Stafford G, Paley M, Anumba D. Cervicovaginal fluid acetate, a marker for preterm birth in symptomatic pregnant women. Reprod Sci. 2016; 23(Suppl 1):81A (O-090).

Stern V, Amabebe E, Reynolds S, Stafford G, Paley M, Anumba D. The association of cervicovaginal fluid metabolites at 20-22 weeks gestation with quantitative fetal fibronectin, ultrasound cervical length, and gestational age at delivery in asymptomatic pregnant women. Reprod Sci. 2016; 23(Suppl 1):190A-191A (F-014).

Parker J, Stafford G, Stern V, Amabebe E, Reynolds S, Paley M, Anumba D. Prognostic microbiomial and metabolite markers of preterm birth in second trimester cervicovaginal fluid from women at risk. Reprod Sci. 2016; 23(Suppl 1):128A (T-86).

Amabebe E, Reynolds S, Stern V, Parker J, Stafford G, Paley M, Anumba D. Elucidating potential metabolite markers of preterm birth in cervicovaginal secretions by Magnetic Resonance Spectroscopy. BJOG. 2015; 122(Suppl 2):103-130 (PP.8). doi: 10.1111/1471-0528.13390.

Stern V, Parker J, Amabebe E, Stafford G, Anumba D. Diversity of the vaginal microbiome and cervicovaginal fetal fibronectin levels: is there an association? BJOG. 2015; 122(Suppl 2):58-58 (PF.13).

Amabebe E, Stern V, Parker J, Reynolds S, Stafford G, Paley M, Anumba D. Elucidating potential metabolite markers of preterm birth in cervicovaginal secretions by Magnetic Resonance Spectroscopy. Reprod Sci. 2015; 22(Suppl 1):130A-130A (T-069).

Narice B, Anumba D. The use of vaginal versus oral misoprostol for priming the cervix prior to hysteroscopy in premenopausal women: a systematic review and meta-analysis of randomised trials. BJOG. 2015; 122(Suppl 4):15.